DSpace at RU >

Search Results

Results 1-50 of 163.

Item hits:

Full Text	Issue Date	Title	Author(s)
	2012	Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus.	Snelders, E.; Camps, S.M.T.; Karawajczyk, A.; Schaftenaar, G.; Kema, G.H.; Lee, H.A.L. van der; Klaassen, C.H.; Melchers, W.J.G.; Verweij, P.E.
	2011	Comment on: Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies	Verweij, P.E.; Camps, S.M.T.; Kema, G.H.; Melchers, W.J.G.
	2011	A Sezary cryptogram. Disseminated cryptococcal infection	Desar, I.M.E.; Stevens, W.B.C.; Verweij, P.E.; Velden, W.J.F.M. van der
	2011	The structure-function relationship of the Aspergillus fumigatuscyp51A L98H conversion by site-directed mutagenesis: the mechanism of L98H azole resistance	Snelders, E.; Karawajczyk, A.; Verhoeven, R.J.; Venselaar, H.; Schaftenaar, G.; Verweij, P.E.; Melchers, W.J.G.
	2011	Assessment of efficacy of antifungals in experimental models of invasive aspergillosis in an era of emerging resistance: the value of real-time quantitative PCR	Seyedmousavi, S.; Melchers, W.J.G.; Verweij, P.E.; Mouton, J.W.
	2011	Pulmonary aspergillosis caused by a pan-azole-resistant Aspergillus fumigatus in a 10-year-old boy	Thors, V.S.; Bierings, M.B.; Melchers, W.J.G.; Verweij, P.E.; Wolfs, T.F.
	2011	Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?	Snelders, E.; Melchers, W.J.G.; Verweij, P.E.
	2011	Failure of posaconazole therapy in a renal transplant patient with invasive aspergillosis due to Aspergillus fumigatus with attenuated susceptibility to posaconazole	Kuipers, S.; Bruggemann, R.J.M.; Sevaux, R.G. de; Heesakkers, J.P.F.A.; Melchers, W.J.G.; Mouton, J.W.; Verweij, P.E.
	2011	Clinical Implications of Azole Resistance in Aspergillus fumigatus, the Netherlands, 2007-2009	Linden, J.W. van der; Snelders, E.; Kampinga, G.A.; Rijnders, B.J.; Mattsson, E.; Debets-Ossenkopp, Y.J.; Kuijper, E.J.; Tiel, F.H. van; Melchers, W.J.G.; Verweij, P.E.
	2011	European expert opinion on the management of invasive candidiasis in adults	Kullberg, B.J.; Verweij, P.E.; Akova, M.; Arendrup, M.C.; Bille, J.; Calandra, T.; Cuenca-Estrella, M.; Herbrecht, R.; Jacobs, F.; Kalin, M.; Kibbler, C.C.; Lortholary, O.; Martino, P.; Meis, J.F.; Munoz, P.; Odds, F.C.; Pauw, B.E. de; Rex, J.H.; Roilides, E.; Rogers, T.R.; Ruhnke, M.; Ullmann, A.J.; Uzun, O.; Vandewoude, K.; Vincent, J.L.; Donnelly, J.P.
	2011	Human leukocytes kill Aspergillus nidulans by reactive oxygen species-independent mechanisms	Henriet, S.S.V.; Hermans, P.W.M.; Verweij, P.E.; Simonetti, E.R.; Holland, S.M.; Sugui, J.A.; Kwon-Chung, K.J.; Warris, A.
	2011	Performance of the new Platelia Candida Plus assays for the diagnosis of invasive Candida infection in patients undergoing myeloablative therapy	Lunel, F.M.; Donnelly, J.P.; Lee, H.A.L. van der; Blijlevens, N.M.A.; Verweij, P.E.
	2011	Calcineurin-dependent galactomannan release in Aspergillus fumigatus	Mennink-Kersten, M.A.S.H.; Ruegebrink, D.; Verweij, P.E.; Steinbach, W.J.
	2011	Aspergillus species intrinsically resistant to antifungal agents	van der Linden, J.W.; Warris, A.; Verweij, P.E.
	2011	Aspergillus fumigatus cell wall components differentially modulate host TLR2 and TLR4 responses	Chai, L.; Vonk, A.G.; Kullberg, B.J.; Verweij, P.E.; Verschueren, I.; Meer, J.W.M. van der; Joosten, L.A.B.; Latge, J.P.; Netea, M.G.
	2011	Impact of therapeutic drug monitoring of voriconazole in a pediatric population	Bruggemann, R.J.M.; Linden, J.W.M. van der; Verweij, P.E.; Burger, D.M.; Warris, A.
	2010	SWAB-richtlijn voor de behandeling van invasieve schimmelinfecties	Oude Lashof, A.M.L.; Janssen, J.J.W.M.; Meis, J.F.G.M.; Warris, A.; Wout, J.W. van 't; Natsch, S.S.; Zanten, A.R. van; Verweij, P.E.; Kullberg, B.J.
	2010	Rapid diagnosis of azole-resistant aspergillosis by direct PCR using tissue specimens.	Linden, J.W.M. van der; Snelders, E.; Arends, J.P.; Daenen, S.M.G.J.; Melchers, W.J.G.; Verweij, P.E.
	2010	Acute Cardiac Failure due to Intra-Atrial Mass Caused by Zygomycetes in an Immunocompromised Paediatric Patient.	Glind, G.J. van de; Gidding, C.E.M.; Verlaat, C.M.; Duthoi, K.E.S.; Backx, A.P.C.M.; Verweij, P.E.; Warris, A.
	2010	Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence.	Arendrup, M.C.; Mavridou, E.; Mortensen, K.L.; Snelders, E.; Frimodt-Moller, N.; Khan, H.; Melchers, W.J.G.; Verweij, P.E.
	2010	Point-of-use filtration method for the prevention of fungal contamination of hospital water.	Warris, A.; Onken, A.; Gaustad, P.; Janssen, W.; Lee, H. van der; Verweij, P.E.; Abrahamsen, T.G.
	2010	Identification of Paecilomyces variotii in clinical samples and settings.	Houbraken, J.; Verweij, P.E.; Rijs, A.J.M.M.; Borman, A.M.; Samson, R.A.
	2010	Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling.	Snelders, E.; Karawajczyk, A.; Schaftenaar, G.; Verweij, P.E.; Melchers, W.J.G.
	2010	Chronic yersiniosis due to defects in the TLR5 and NOD2 recognition pathways.	Netea, M.G.; Leij, F. van der; Drenth, J.P.H.; Joosten, L.A.B.; Morsche, R.H.M. te; Verweij, P.E.; Jong, D. de; Kullberg, B.J.; Meer, J.W.M. van der
	2010	Impact of cyp51A mutations on the pharmacokinetic and pharmacodynamic properties of voriconazole in a murine model of disseminated aspergillosis.	Mavridou, E.; Bruggemann, R.J.M.; Melchers, W.J.G.; Verweij, P.E.; Mouton, J.W.
	2010	Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene.	Mavridou, E.; Bruggemann, R.J.M.; Melchers, W.J.G.; Mouton, J.W.; Verweij, P.E.
	2010	Genetic variation of innate immune genes in HIV-infected african patients with or without oropharyngeal candidiasis.	Plantinga, T.S.; Hamza, O.; Willment, J.A.; Ferwerda, B.; Geer, N.M. van de; Verweij, P.E.; Matee, M.I.N.; Banahan, K.; O'Neill, L.A.; Kullberg, B.J.; Brown, G.D.; Ven, A.J.A.M. van der; Netea, M.G.
	2009	Fatal consequences of an ear infection.	Stalpers, X.L.; Smink-Bol, M.; Verweij, P.E.; Wesseling, P.; Dijk, G.W. van
	2009	The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Moulds: diagnosis and treatment.	Verweij, P.E.; Maertens, J.
	2009	International interlaboratory proficiency testing program for measurement of azole antifungal plasma concentrations.	Bruggemann, R.J.M.; Touw, D.J.; Aarnoutse, R.E.; Verweij, P.E.; Burger, D.M.
	2009	Azole-resistant central nervous system aspergillosis.	Linden, J.W.M. van der; Jansen, R.R.; Bresters, D.; Visser, C.E.; Geerlings, S.E.; Kuijper, E.J.; Melchers, W.J.G.; Verweij, P.E.
	2009	Value of Candida serum markers in patients with invasive candidiasis after myeloablative chemotherapy.	Lunel, F.M.; Mennink-Kersten, M.A.S.H.; Ruegebrink, D.; Lee, H.A.L. van der; Donnelly, J.P.; Blijlevens, N.M.A.; Verweij, P.E.
	2009	Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents.	Bruggemann, R.J.M.; Alffenaar, J.W.C.; Blijlevens, N.M.A.; Billaud, E.M.; Kosterink, J.G.W.; Verweij, P.E.; Burger, D.M.
	2009	Trends in invasive fungal infections, with emphasis on invasive aspergillosis.	Erjavec, Z.; Kluin-Nelemans, H.C.; Verweij, P.E.
	2009	Azole-resistance in Aspergillus: proposed nomenclature and breakpoints.	Verweij, P.E.; Howard, S.J.; Melchers, W.J.G.; Denning, D.W.
	2009	Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?	Verweij, P.E.; Snelders, E.; Kema, G.H.; Mellado, E.; Melchers, W.J.G.
	2009	In vitro antifungal activity of isavuconazole against 345 mucorales isolates collected at study centers in eight countries.	Verweij, P.E.; Gonzalez, G.M.; Wiedrhold, N.P.; Lass-Florl, C.; Warn, P.; Heep, M.; Ghannoum, M.A.; Guinea, J.
	2009	Azoolresistente invasieve aspergillose	Linden, J.W.M. van der; Warris, A.; Meer, J.W.M. van der; Bresters, D.; Melchers, W.J.G.; Verweij, P.E.
	2009	Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery.	Hodiamont, C.J.; Dolman, K.M.; Berge, I.J. Ten; Melchers, W.J.G.; Verweij, P.E.; Pajkrt, D.
	2009	Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles.	Snelders, E.; Huis In 't Veld, R.A.; Rijs, A.J.M.M.; Kema, G.H.; Melchers, W.J.G.; Verweij, P.E.
	2009	Timing and dose of tissue plasminogen activator to prevent abscess formation after surgical treatment of secondary peritonitis in the rat.	Buyne, O.R.; Goor, H. van; Verweij, P.E.; Bleichrodt, R.P.; Hendriks, T.
	2009	Tissue-type plasminogen activator prevents abscess formation but does not affect healing of bowel anastomoses and laparotomy wounds in rats with secondary peritonitis.	Buyne, O.R.; Bleichrodt, R.P.; Man, B.M. de; Lomme, R.M.L.M.; Verweij, P.E.; Goor, H. van; Hendriks, T.
	2009	Circulating Candida-specific anti-mannan antibodies precede invasive candidiasis in patients undergoing myelo-ablative chemotherapy.	Verduyn Lunel, F.M.; Donnelly, J.P.; Lee, H.A.L. van der; Blijlevens, N.M.A.; Verweij, P.E.
	2008	Pseudomonas aeruginosa as a cause of 1,3-beta-D-glucan assay reactivity.	Mennink-Kersten, M.A.S.H.; Ruegebrink, D.; Verweij, P.E.
	2008	Anidulafungine (Ecalta)	Meulwijk, E.W. van; Brüggemann, R.J.M.; Verweij, P.E.; Burger, D.M.
	2008	Cutane nodulus als uiting van systemische cryptococcose bij een levertransplantatie patient	Schade, R.P.; Peters, B.; Oude Lashof, A.M.L.; Kullberg, B.J.; Verweij, P.E.
	2008	Aanvulling bij gecompliceerde gistinfecties. Anidulafungine (Ecalta).	Muilwijk, E.W. van; Brüggemann, R.J.M.; Verweij, P.E.; Burger, D.M.
	2008	Invasieve zygomycose bij patiënten die worden behandeld voor een hematologische maligniteit	Verweij, P.E.; Velden, W.J.F.M. van der; Donnelly, P.; Blijlevens, N.M.A.; Warris, A.
	2008	EUCAST technical note on fluconazole	Rodriquez Tudela, J.L.; Donnelly, J.P.; Arendrup, M.C.; Arikan, S.; Barchiesi, F.; Bille, J.; Chryssanthou, E.; Cuenca-Estrella, M.; Dannaoui, E.; Denning, D.W.; Fegeler, W.; Gaustad, P.; Klimko, N.; Lass-Florl, C.; Moore, C.; Richardson, M.; Schmalreck, A.; Stenderup, J.; Velegraki, A.; Verweij, P.E.
	2008	EUCAST Technical Note on voriconazole.	Rodriguez-Tudela, J.L.; Donnelly, J.P.; Arendrup, M.C.; Arikan, S.; Barchiesi, F.; Bille, J.; Chryssanthou, E.; Cuenca-Estrella, M.; Dannaoui, E.; Denning, D.W.; Fegeler, W.; Gaustad, P.; Lass-Florl, C.; Moore, C.; Richardson, M.; Schmalreck, A.; Velegraki, J.A.; Verweij, P.E.

1 2 3 4 next